In addition to growth inhibition, recent work has implicated TGF-β in other processes involved in tumour inhibition including maintenance of genomic stability, induction of senescence, suppression of telomerase activity and prevention of inappropriate angiogenesis (Wakefield and Roberts, 2002). This evidence concerns the gene TGFB1 and neoplasm.